CloudMD to Present at Canaccord Genuity 40th Annual Growth Conference
VANCOUVER, British Columbia, July 30, 2020 (GLOBE NEWSWIRE) — CloudMD Software & Services Inc. (TSXV: DOC, OTCQB: DOCRF, Frankfurt: 6PH) […]
BetterLife Pharma Receives Approval from Altum Pharmaceuticals Inc. Shareholders to Complete Merger
Vancouver, July 30, 2020 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / […]
Ryerson University Chooses NexTech’s InfernoAR for Augmented Reality Remote Learning Solutions
Paradigm Shift To Remote Education and AR AcceleratingRyerson enjoys first-mover advantage by launching RALE – the Ryerson Augmented Learning Experience […]
Navios Maritime Acquisition Corporation Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2020
Revenue ° 91.6% increase in Q2 2020 revenue to $112.2 million ° 54.8% increase in H1 2020 […]
Lexicon Realigns Business Around Research and Development Assets, with Focus on Phase 2 LX9211 Neuropathic Pain Program
Phase 2 Study for Diabetic Peripheral Neuropathic Pain Underway, Additional Studies Planned in Other Areas of Neuropathic PainSale of XERMELO […]
Quinsam Announces Dividend, Intent to Renew Issuer Bid & Update
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION BY ANY UNITED STATES NEWS DISTRIBUTION SERVICETORONTO, July 30, 2020 […]
TSX News -
Husky Energy Announces Second Quarter 2020 Dividend and Third Quarter 2020 Preferred Shares Dividend Payments
CALGARY, Alberta, July 30, 2020 (GLOBE NEWSWIRE) — Husky Energy’s Board of Directors has approved a quarterly dividend of $0.0125 […]
TSX News -
Husky Energy Reports Second Quarter 2020 Results
This news release contains references to the non-GAAP financial measures “funds from operations”, “free cash flow”, “net debt”, “operating margin”, […]
TSX News -
MAYA GOLD & SILVER INC. ANNOUNCES NAME CHANGE AND POSTPONEMENT OF FILING ITS Q2 FINANCIAL STATEMENTS
Montreal, Québec, July 30, 2020 (GLOBE NEWSWIRE) — Maya Gold & Silver Inc. ( ”Maya” or the “Corporation”) (TSX: MYA) […]
TSX News -
Trillium Therapeutics Provides Update On Phase 1 Study Of TTI-621 And Dose Escalation To 2.0 MG/KG Level
CAMBRIDGE, Mass., July 30, 2020 (GLOBE NEWSWIRE) — Trillium Therapeutics Inc. (“Trillium” or the “Company”) (NASDAQ/TSX:TRIL), a clinical stage immuno-oncology […]
